Literature DB >> 33604297

Tumor Microenvironment Autophagic Processes and Cachexia: The Missing Link?

Renata de Castro Gonçalves1, Paula Paccielli Freire2, Dario Coletti3,4, Marilia Seelaender1.   

Abstract

Cachexia is a syndrome that affects the entire organism and presents a variable plethora of symptoms in patients, always associated with continuous and involuntary degradation of skeletal muscle mass and function loss. In cancer, this syndrome occurs in 50% of all patients, while prevalence increases to 80% as the disease worsens, reducing quality of life, treatment tolerance, therapeutic response, and survival. Both chronic systemic inflammation and immunosuppression, paradoxically, correspond to important features in cachexia patients. Systemic inflammation in cachexia is fueled by the interaction between tumor and peripheral tissues with significant involvement of infiltrating immune cells, both in the peripheral tissues and in the tumor itself. Autophagy, as a process of regulating cellular metabolism and homeostasis, can interfere with the metabolic profile in the tumor microenvironment. Under a scenario of balanced autophagy in the tumor microenvironment, the infiltrating immune cells control cytokine production and secretion. On the other hand, when autophagy is unbalanced or dysfunctional within the tumor microenvironment, there is an impairment in the regulation of immune cell's inflammatory phenotype. The inflammatory phenotype upregulates metabolic consumption and cytokine production, not only in the tumor microenvironment but also in other tissues and organs of the host. We propose that cachexia-related chronic inflammation can be, at least, partly associated with the failure of autophagic processes in tumor cells. Autophagy endangers tumor cell viability by producing immunogenic tumor antigens, thus eliciting the immune response necessary to counteract tumor progression, while preventing the establishment of inflammation, a hallmark of cachexia. Comprehensive understanding of this complex functional dichotomy may enhance cancer treatment response and prevent/mitigate cancer cachexia. This review summarizes the recent available literature regarding the role of autophagy within the tumor microenvironment and the consequences eliciting the development of cancer cachexia.
Copyright © 2021 Gonçalves, Freire, Coletti and Seelaender.

Entities:  

Keywords:  DAMPs; autophagy; cachexia; lymphocyte infiltration; metabolism; systemic inflammations; tumor microenvironment

Year:  2021        PMID: 33604297      PMCID: PMC7884816          DOI: 10.3389/fonc.2020.617109

Source DB:  PubMed          Journal:  Front Oncol        ISSN: 2234-943X            Impact factor:   6.244


  49 in total

Review 1.  The autophagic tumor stroma model of cancer or "battery-operated tumor growth": A simple solution to the autophagy paradox.

Authors:  Ubaldo E Martinez-Outschoorn; Diana Whitaker-Menezes; Stephanos Pavlides; Barbara Chiavarina; Gloria Bonuccelli; Trimmer Casey; Aristotelis Tsirigos; Gemma Migneco; Agnieszka Witkiewicz; Renee Balliet; Isabelle Mercier; Chengwang Wang; Neal Flomenberg; Anthony Howell; Zhao Lin; Jaime Caro; Richard G Pestell; Federica Sotgia; Michael P Lisanti
Journal:  Cell Cycle       Date:  2010-11-30       Impact factor: 4.534

Review 2.  Paradoxical Role of HMGB1 in Pancreatic Cancer: Tumor Suppressor or Tumor Promoter?

Authors:  María José García Cebrián; Monika Bauden; Roland Andersson; Stefan Holdenrieder; Daniel Ansari
Journal:  Anticancer Res       Date:  2016-09       Impact factor: 2.480

Review 3.  Cargo recognition and trafficking in selective autophagy.

Authors:  Alexandra Stolz; Andreas Ernst; Ivan Dikic
Journal:  Nat Cell Biol       Date:  2014-06       Impact factor: 28.824

Review 4.  Metabolic pathways in T cell activation and lineage differentiation.

Authors:  Luís Almeida; Matthias Lochner; Luciana Berod; Tim Sparwasser
Journal:  Semin Immunol       Date:  2016-11-04       Impact factor: 11.130

5.  Prevalence of malnutrition and current use of nutrition support in patients with cancer.

Authors:  Xavier Hébuterne; Etienne Lemarié; Mauricette Michallet; Claude Beauvillain de Montreuil; Stéphane Michel Schneider; François Goldwasser
Journal:  JPEN J Parenter Enteral Nutr       Date:  2014-02       Impact factor: 4.016

Review 6.  Interplay between ROS and autophagy in cancer cells, from tumor initiation to cancer therapy.

Authors:  Laura Poillet-Perez; Gilles Despouy; Régis Delage-Mourroux; Michaël Boyer-Guittaut
Journal:  Redox Biol       Date:  2014-12-10       Impact factor: 11.799

7.  Toll-like receptor 4 mediates Lewis lung carcinoma-induced muscle wasting via coordinate activation of protein degradation pathways.

Authors:  Guohua Zhang; Zhelong Liu; Hui Ding; Hongyu Miao; Jose M Garcia; Yi-Ping Li
Journal:  Sci Rep       Date:  2017-05-23       Impact factor: 4.379

Review 8.  Targeting Autophagy to Overcome Human Diseases.

Authors:  Maria Condello; Evelin Pellegrini; Michele Caraglia; Stefania Meschini
Journal:  Int J Mol Sci       Date:  2019-02-08       Impact factor: 5.923

Review 9.  Crosstalk between cancer and immune cells: Role of tumor-associated macrophages in the tumor microenvironment.

Authors:  Jing Wang; Danyang Li; Huaixing Cang; Bo Guo
Journal:  Cancer Med       Date:  2019-06-20       Impact factor: 4.452

Review 10.  The crosstalk between autophagic and endo-/exosomal pathways in antigen processing for MHC presentation in anticancer T cell immune responses.

Authors:  Liangshun You; Liping Mao; Juying Wei; Shenhe Jin; Chunmei Yang; Hui Liu; Li Zhu; Wenbin Qian
Journal:  J Hematol Oncol       Date:  2017-10-23       Impact factor: 17.388

View more
  4 in total

1.  Editorial: Myokines, Adipokines, Cytokines in Muscle Pathophysiology, Volume II.

Authors:  Valentina Di Felice; Dario Coletti; Marilia Seelaender
Journal:  Front Physiol       Date:  2022-05-30       Impact factor: 4.755

2.  Association of Systemic Inflammation and Overall Survival in Elderly Patients with Cancer Cachexia - Results from a Multicenter Study.

Authors:  Guo-Tian Ruan; Ming Yang; Xiao-Wei Zhang; Meng-Meng Song; Chun-Lei Hu; Yi-Zhong Ge; Hai-Lun Xie; Tong Liu; Meng Tang; Qi Zhang; Xi Zhang; Kang-Ping Zhang; Xiang-Rui Li; Qin-Qin Li; Yong-Bing Chen; Kai-Ying Yu; Ming-Hua Cong; Kun-Hua Wang; Han-Ping Shi
Journal:  J Inflamm Res       Date:  2021-10-27

3.  M5C regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in lung adenocarcinoma.

Authors:  Hui Chen; Xiao-Lin Ge; Zhao-Yue Zhang; Ming Liu; Rui-Yan Wu; Xiao-Fei Zhang; Li-Ping Xu; Hong-Yan Cheng; Xin-Chen Sun; Hong-Cheng Zhu
Journal:  Transl Lung Cancer Res       Date:  2021-05

4.  Application Route and Immune Status of the Host Determine Safety and Oncolytic Activity of Oncolytic Coxsackievirus B3 Variant PD-H.

Authors:  Ahmet Hazini; Babette Dieringer; Karin Klingel; Markian Pryshliak; Anja Geisler; Dennis Kobelt; Ole Daberkow; Jens Kurreck; Sophie van Linthout; Henry Fechner
Journal:  Viruses       Date:  2021-09-24       Impact factor: 5.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.